| Indicators | Browse All

eXoZymes, Inc. (EXOZ)

Healthcare | Biotechnology | Monrovia, United States | NasdaqCM
4.59 USD -0.46 (-9.109%) ⇩ (Oct. 13, 2026, 4 p.m. EDT)

Short-term:★☆☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 9:23 a.m. EDT

The immediate outlook is severely clouded by a massive disconnect between the company's financial reality and its market valuation. Despite a 'strong buy' recommendation likely driven by recent capital raises and a new NIH grant, the stock trades at a price-to-book ratio of over 13x while reporting negative earnings, negative free cash flow, and negative returns on both assets and equity. This suggests the market is pricing in a speculative turnaround rather than current operational success, creating a fragile foundation for any short-term rally. The recent news of a public offering and unit deals indicates a desperate need for liquidity, which often precedes further dilution or volatility rather than sustainable growth. Without a proven path to profitability or a dominant market position that justifies such a premium over book value, the risk of a value trap is high, making this a poor candidate for either quick gains or long-term holding.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.245702
AutoARIMA0.253676
AutoTheta0.259611
AutoETS0.332714

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 32%
H-stat 4.82
Ljung-Box p 0.000
Jarque-Bera p 0.110
Excess Kurtosis -0.34
Attribute Value
Sector Healthcare
Debt to Equity Ratio 29.694
Market Cap 42,708,580
Previous Name Invizyne Technologies, Inc.
Website https://www.exozymes.com

Info Dump

Attribute Value
52 Week Change -0.61123943
Address1 750 Royal Oaks Drive
Address2 Suite 106
All Time High 23.99
All Time Low 4.35
Ask 7.6
Ask Size 1
Average Analyst Rating 0.0 - Strong Buy
Average Daily Volume10 Day 5,330
Average Daily Volume3 Month 6,817
Average Volume 6,817
Average Volume10Days 5,330
Bid 6.1
Bid Size 1
Book Value 0.394
City Monrovia
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 4.59
Current Ratio 3.813
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 5.0476
Day Low 4.55
Debt To Equity 29.694
Display Name eXoZymes
Dividend Yield 0.0
Earnings Call Timestamp End 1,747,083,600
Earnings Call Timestamp Start 1,747,083,600
Earnings Timestamp End 1,747,047,540
Earnings Timestamp Start 1,747,047,540
Ebitda -10,262,264
Ebitda Margins 0.0
Enterprise To Ebitda -3.706
Enterprise Value 38,033,776
Eps Trailing Twelve Months -1.08
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 6.1198
Fifty Day Average Change -1.5297999
Fifty Day Average Change Percent -0.24997547
Fifty Two Week Change Percent -61.123943
Fifty Two Week High 18.4
Fifty Two Week High Change -13.809999
Fifty Two Week High Change Percent -0.7505435
Fifty Two Week Low 4.35
Fifty Two Week Low Change 0.24000025
Fifty Two Week Low Change Percent 0.055172473
Fifty Two Week Range 4.35 - 18.4
Financial Currency USD
First Trade Date Milliseconds 1,731,508,200,000
Float Shares 7,165,116
Free Cashflow -3,252,423
Full Exchange Name NasdaqCM
Full Time Employees 32
Fullday Change -0.5
Fullday Change Percent -9.823182
Fullday Price 4.59
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.65353996
Held Percent Institutions 0.013359999
Implied Shares Outstanding 9,304,701
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Long Name eXoZymes, Inc.
Market us_market
Market Cap 42,708,580
Market State PREPRE
Max Age 86,400
Message Board Id finmb_1687004448
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-10-14
Net Income To Common -10,190,888
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 59,215,070
Open 5.0476
Operating Cashflow -6,995,227
Operating Margins 0.0
Phone 626 415 1488
Prev Name Invizyne Technologies, Inc.
Previous Close 5.05
Price Hint 4
Price To Book 11.649747
Profit Margins 0.0
Quick Ratio 3.63
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 0.0
Region US
Regular Market Change -0.46000004
Regular Market Change Percent -9.1089115
Regular Market Day High 5.0476
Regular Market Day Low 4.55
Regular Market Day Range 4.55 - 5.0476
Regular Market Open 5.0476
Regular Market Previous Close 5.05
Regular Market Price 4.59
Regular Market Time 1,791,921,600
Regular Market Volume 20,379
Return On Assets -0.74738
Return On Equity -1.87164
Sand P52 Week Change 0.17502642
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 9,304,701
Shares Percent Shares Out 0.002
Shares Short 18,469
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 21,807
Short Name eXoZymes Inc.
Short Percent Of Float 0.0037
Short Ratio 2.43
Source Interval 15
State CA
Symbol EXOZ
Total Cash 5,652,696
Total Cash Per Share 0.609
Total Debt 1,085,035
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.08
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 8.22515
Two Hundred Day Average Change -3.63515
Two Hundred Day Average Change Percent -0.44195545
Type Disp Equity
Volume 20,379
Website https://www.exozymes.com
Zip 91,016